BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10417424)

  • 21. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene.
    Tolkacheva T; Chan AM
    Oncogene; 2000 Feb; 19(5):680-9. PubMed ID: 10698513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.
    Besson A; Robbins SM; Yong VW
    Eur J Biochem; 1999 Aug; 263(3):605-11. PubMed ID: 10469123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
    Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
    Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genes & cancer. Card no. 28: PTEN (MMAC, TEP-1) (phosphatase and tensin homolog deleted on chromosome 10)].
    Soussi T
    Bull Cancer; 1999 Sep; 86(9):715-6. PubMed ID: 10576807
    [No Abstract]   [Full Text] [Related]  

  • 25. Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene.
    Minaguchi T; Mori T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
    Cancer Res; 1999 Dec; 59(24):6063-7. PubMed ID: 10626791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity.
    Gildea JJ; Herlevsen M; Harding MA; Gulding KM; Moskaluk CA; Frierson HF; Theodorescu D
    Oncogene; 2004 Sep; 23(40):6788-97. PubMed ID: 15273733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of action of the tumour suppressor gene PTEN.
    Hlobilková A; Knillová J; Bártek J; Lukás J; Kolár Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):19-25. PubMed ID: 15034601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.
    Maier D; Jones G; Li X; Schönthal AH; Gratzl O; Van Meir EG; Merlo A
    Cancer Res; 1999 Nov; 59(21):5479-82. PubMed ID: 10554022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.
    Wick W; Furnari FB; Naumann U; Cavenee WK; Weller M
    Oncogene; 1999 Jul; 18(27):3936-43. PubMed ID: 10435616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
    Li DM; Sun H
    Cancer Res; 1997 Jun; 57(11):2124-9. PubMed ID: 9187108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN, a unique tumor suppressor gene.
    Dahia PL
    Endocr Relat Cancer; 2000 Jun; 7(2):115-29. PubMed ID: 10903528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases.
    Liliental J; Moon SY; Lesche R; Mamillapalli R; Li D; Zheng Y; Sun H; Wu H
    Curr Biol; 2000 Apr; 10(7):401-4. PubMed ID: 10753747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
    Han SY; Kato H; Kato S; Suzuki T; Shibata H; Ishii S; Shiiba K; Matsuno S; Kanamaru R; Ishioka C
    Cancer Res; 2000 Jun; 60(12):3147-51. PubMed ID: 10866302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conserved synteny between the Fugu and human PTEN locus and the evolutionary conservation of vertebrate PTEN function.
    Yu WP; Pallen CJ; Tay A; Jirik FR; Brenner S; Tan YH; Venkatesh B
    Oncogene; 2001 Sep; 20(39):5554-61. PubMed ID: 11571655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The multiple roles of PTEN in tumor suppression.
    Di Cristofano A; Pandolfi PP
    Cell; 2000 Feb; 100(4):387-90. PubMed ID: 10693755
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell cycle arrest and astrocytic differentiation resulting from PTEN expression in glioma cells.
    Adachi J; Ohbayashi K; Suzuki T; Sasaki T
    J Neurosurg; 1999 Nov; 91(5):822-30. PubMed ID: 10541240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expanding role of PTEN in neoplasia: a molecule for all seasons? Commentary re: M. A. Davies, et al., Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin. Cancer Res., 8: 1904-1914, 2002.
    Fernandez M; Eng C
    Clin Cancer Res; 2002 Jun; 8(6):1695-8. PubMed ID: 12060605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome 10 alterations in prostate adenocarcinoma (review).
    Ittmann MM
    Oncol Rep; 1998; 5(6):1329-35. PubMed ID: 9769364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of PTEN promotes tumor development in malignant melanoma.
    Stahl JM; Cheung M; Sharma A; Trivedi NR; Shanmugam S; Robertson GP
    Cancer Res; 2003 Jun; 63(11):2881-90. PubMed ID: 12782594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray.
    Hong TM; Yang PC; Peck K; Chen JJ; Yang SC; Chen YC; Wu CW
    Am J Respir Cell Mol Biol; 2000 Sep; 23(3):355-63. PubMed ID: 10970827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.